PEDIATRICS Vol. 76 No. 2 August 1985, pp. 280-285
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Freundlich, M.
Right arrow Articles by Strauss, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Freundlich, M.
Right arrow Articles by Strauss, J.

Bone Modulating Factors in Nephrotic Children with Normal Glomerular Filtration Rate

Michael Freundlich MD1, Jacques J. Bourgoignie MD1, Gaston Zilleruelo MD1, Allan I. Jacob MD1, Janet M. Canterbury PhD1, and Jose Strauss MD1

1 From the Departments of Pediatrics and Medicine, University of Miami School of Medicine, Miami

Factors influencing bone and mineral metabolism were evaluated in 16 children with active nephrotic syndrome and normal glomerular filtration rate. All patients were proteinuric and/or hypoalbuminemic and had elevated serum triglyceride and cholesterol levels. Seven patients had never received or had discontinued glucocorticoid treatment at least 6 months before the study; six patients were receiving prednisone at the time of study. Although all patients were hypocalcemic (serum total or ionized calcium), none was hypomagnesemic. Despite the low serum calcium levels, circulating immunoreactive parathyroid hormone was elevated in only nine of 16. Plasma 25-hydroxyvitamin D was low in all 16 patients, averaging 7.6 ± 1.2 ng/mL for the group. In contrast, levels of 1,25-dihydroxyvitamin D were normal in 12 of 14 patients. Bone mineral content measured by photon absorptiometry averaged 83% and was less than 90% of normal in six of nine patients tested. The findings were not influenced by the recent or concurrent administration of glucocorticoid. The data demonstrate abnormalities of mineral and bone modulation in nephrotic children even in the absence of impaired glomerular filtration rate and irrespective of glucocorticoid therapy. The decrease in serum ionized calcium may be related to an absolute deficiency in 25-hydroxyvitamin D and/or a relative deficiency in 1,25-dihydroxyvitamin D. Undermineralization of bone may result from the low levels of vitamin D metabolites and, in some patients, from an increase in immunoreactive parathyroid hormone. Whether treatment with vitamin D metabolites and/or calcium supplementation will prevent the abnormalities remains to be demonstrated.

Key Words: nephrotic syndrome • parathyroid hormone • vitamin D • hypocalcemia • bone mineralization

Submitted on April 24, 1984




This article has been cited by other articles:


Home page
 J. Am. Soc. Nephrol.Home page
M. Freundlich, E. Alonzo, E. Bellorin-Font, and J. R. Weisinger
Increased Osteoblastic Activity and Expression of Receptor Activator of NF-{kappa}B Ligand in Nonuremic Nephrotic Syndrome
J. Am. Soc. Nephrol., July 1, 2005; 16(7): 2198 - 2204.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
M. B. Leonard, H. I. Feldman, J. Shults, B. S. Zemel, B. J. Foster, and V. A. Stallings
Long-Term, High-Dose Glucocorticoids and Bone Mineral Content in Childhood Glucocorticoid-Sensitive Nephrotic Syndrome
N. Engl. J. Med., August 26, 2004; 351(9): 868 - 875.
[Abstract] [Full Text] [PDF]